Aspyra, Inc. (AMEX:APY) today announced plans to debut the All-in-One PACS and RIS/PACS solutions at the upcoming RSNA 2008 Annual Meeting held at McCormick Place in Chicago, IL (November 30 � December 4, 2008), Booth 6610, South Building Hall A. Aspyra�s All-in-One PACS and All-in-One RIS/PACS provide cost-effective solutions for the cost-conscious hospital, imaging center and orthopedic group practice. The economical, all-inclusive package includes Aspyra�s complete PACS or RIS/PACS software application, server, webserver, primary on-line RAID 6 archive storage, secondary DVD archive storage (enabling HIPAA compliant off-site storage backup), system backup DVDs and patient CD creator. Aspyra�s PACS, Specialty PACS and RIS/PACS solutions are designed to meet the needs of acute care hospitals, enterprise-wide delivery networks, medium to large imaging centers, and orthopedic group practices, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow. Bill Culton, Aspyra�s Diagnostic Solutions Product Manager, states, �With the current economic condition of our nation, coupled with reimbursement and other financial concerns, Aspyra can offer the healthcare organization affordable solutions that enable the caregiver to provide quality care, improve business efficiencies and productivity, without breaking the bank.� About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025 Aspyra 차트를 더 보려면 여기를 클릭.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025 Aspyra 차트를 더 보려면 여기를 클릭.